Medici List

A private Delaware limited liability company formed in 2021 that operates as a REIT-focused investment fund targeting U.S. commercial real estate debt and related assets, managed by an SEC-registered investment manager.

Absci is a clinical-stage biopharmaceutical company that uses an AI-native Integrated Drug Creation platform to design and rapidly validate antibody therapeutics and advances internal programs while generating partner-derived revenue.

Clinical-stage biopharmaceutical company developing oral small-molecule TAS2R agonists (lead ARD-101) to stimulate endogenous gut hormones and suppress hunger for metabolic diseases.

Consumer products company that owns and markets multiple consumer brands and primarily sells online through e-commerce marketplaces (predominantly Amazon US) and direct-to-consumer websites.

Avalo Therapeutics is a clinical-stage biotechnology company developing abdakibart (AVTX-009), a high-affinity anti-IL-1β monoclonal antibody primarily for hidradenitis suppurativa, currently in a Phase 2 LOTUS trial with topline data expected in Q2 2026 and no approved products to date.

Arbutus Biopharma is a clinical-stage biopharmaceutical company focused on developing curative therapies for chronic hepatitis B, advancing RNAi therapeutic AB-729 (imdusiran) and oral PD-L1 inhibitor AB-101 while monetizing LNP/IP through collaborations and licensing.

Ambarella designs and sells low-power system-on-chip processors and software for edge and physical AI, enabling on-device multi-modal sensor fusion and inference for IoT, automotive, robotics, and edge computing applications.

Ashford Hospitality Trust, Inc. is a real estate investment trust that owns and finances a portfolio of upscale and upper-upscale full-service hotels in the U.S., contracting hotel operations to third-party managers and relying on Ashford LLC for advisory and asset-management services.

Pre-commercial low-carbon energy company developing and commercializing licensed and proprietary pyrolysis and upgrading technologies to convert waste plastics and biomass into refinery-compatible renewable fuels and chemical feedstocks, with development hub planned at Cedar Port (Baytown, TX) and non-material legacy oil and gas operations.

Cayman Islands-domiciled special purpose acquisition company (SPAC) formed September 19, 2025 to effect an initial business combination (primarily targeting FinTech, SaaS, or AI), raised $248.5 million in a February 19, 2026 IPO (proceeds placed in a trust), has two executive officers, no operations or customers, and must complete a qualifying business combination within 18 months.

Bitwise Chainlink ETF (CLNK) is an exchange-traded product structured as a Delaware statutory trust that holds Chainlink to provide market exposure to Chainlink via NYSE Arca, sponsored and administered by Bitwise Investment Advisers, LLC.

Acquisition AI Infrastructure Corp. is a Cayman Islands exempted special purpose acquisition company (SPAC) formed to combine with high-impact AI/ML and next-generation data center infrastructure businesses and had no operating revenue as of December 31, 2025.